Metastatic Uveal Malignant Melanoma: A Case Report by Walter, MD, James W. et al.
The Medicine Forum
Volume 14 Article 20
2013
Metastatic Uveal Malignant Melanoma: A Case
Report
James W. Walter, MD
Thomas Jefferson University Hospitals, James.Walter@jefferson.edu
Rebecca Matro, MD
Thomas Jefferson University Hospitals, Rebecca.Matro@jefferson.edu
Daniel M. Quirk, MD, MPH
Thomas Jefferson University Hospitals, Daniel.M.Quirk@jefferson.edu
Follow this and additional works at: http://jdc.jefferson.edu/tmf
Part of the Medicine and Health Sciences Commons
Let us know how access to this document benefits you
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
The Medicine Forum by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Walter, MD, James W.; Matro, MD, Rebecca; and Quirk, MD, MPH, Daniel M. (2013) "Metastatic Uveal Malignant Melanoma: A
Case Report," The Medicine Forum: Vol. 14, Article 20.
Available at: http://jdc.jefferson.edu/tmf/vol14/iss1/20
46
Case Report
A 77-year-old woman presented with a chief complaint of 
one day history of severe, acute abdominal pain. The patient 
described the pain as “intense,” non-radiating, and located 
primarily in the left upper abdominal quadrant. The pain was 
associated with nausea and multiple episodes of non-bilious, 
non-bloody emesis. She denied melena and hematochezia. On 
physical examination, her abdomen was soft and exquisitely 
tender in the left upper quadrant and epigastric regions. Aside 
from trace lower extremity edema, the remainder of her physical 
examination was unremarkable. Laboratory results at the time 
of admission were notable for: hemoglobin 10.8 g/dL, alkaline 
phosphatase 459 U/L, aspartate transaminase 56 U/L, and 
alanine transaminase 66 U/L.
The patient’s past medical history was significant for 
hypertension, gastroesophageal reflux disease, papillary thyroid 
carcinoma, and right eye uveal melanoma. The ocular melanoma 
was treated 16 years ago with radioactive plaque followed by 
transpupillary thermal therapy. The patient was diagnosed 
with metastatic disease to her liver approximately 6 years prior 
and she had received several rounds of hepatic radiation and 
chemotherapeutic embolizations. The patient’s oncologist 
closely monitored her for disease progression through regular 
abdominal imaging studies.
An esophagogastroduodenoscopy revealed a normal esophagus, 
numerous hyperpigmented flat to slightly raised lesions 
throughout the stomach, particularly in the proximal body and 
fundus (Figures 1, 2), and a 2 mm lesion in the duodenal bulb 
Histopathology and immunohistochemical staining of these 
lesions confirmed metastatic malignant melanoma (Figure 3). 
Discussion
The incidence of cutaneous malignant melanoma is rising at 
a rate faster than that of any other malignancy.1 Melanoma is 
notorious for its aggressive ability to metastasize to nearly every 
part of the body, with the liver, lung, and bone being the most 
common sites.2 With specific regards to uveal melanoma (UM), 
it is the second most common form of melanoma.3 Unlike 
the cutaneous form, UM’s incidence rate has remained stable 
over the years. UM can arise anywhere within the uveal tract 
(iris, ciliary body and choroid) and spreads hematogenously. 
Hematogenous spread is favored over lymphatic spread due to 
the lack of sufficient lymphatic drainage.4,5
Melanoma’s particular affinity for metastasizing to the gastro-
intestinal (GI) tract has been well described in the literature. GI 
involvement has been found in up to 60% of primary cutaneous 
malignant melanoma patients at autopsy and is commonly 
associated with invasive visceral organ disease. Given the highly 
vascularized nature of the small bowel, it is the most common 
site of GI tract metastasis. Stomach involvement comprises 
approximately 20% of GI tract metastasis cases Antemortum 
diagnoses of GI metastasis are made in only 1% - 4% of patients 
with malignant melanoma . Such a diagnosis can go clinically 
undetected until years after the initial diagnosis.6-8
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Figure 1. Metastatic malignant melanoma lesions within  
gastric body.
Figure 2. Closer endoscopic view of a lesion.
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Endoscopically, metastatic melanoma can be polypoid in nature, 
is frequently ulcerated, and is either pigmented or amelaontic.8 
Large polypoidal lesions can be obstructive in nature and can 
act as lead points for intussusception. Submucosal nodules with 
similar characteristics have also been seen. 
Symptoms of GI melanoma metastasis tend to be inconspicuous 
and nonspecific. Patients may report vague abdominal pain, 
weight loss, nausea/vomiting, and/or malaise. Anemia may also 
be seen as a result of slow, chronic blood loss from ulcerated lesion 
sites giving rise to melena. Such symptoms should raise suspicion 
in patients with a known history of melanoma. However, with a 
median survival time of less than six months after confirmed GI 
involvement, the prognosis is generally very poor.6
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Figure 3. Biopsy histopathology showing invasion of malignant 
melanocytes into gastric mucosa.
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